Daniel Wagner

Daniel Wagner

Director/Board Member at
SAMI Health, Inc.
55 year
Health Technology
Health Services
Consumer Services

Profile

Daniel Wagner is currently Director at Biorez, Inc., SAMI Health, Inc., AlloMek Therapeutics LLC, and Tangen Biosciences, Inc., and Senior Managing Director at New Haven Pharmaceuticals, Inc. Former roles include Director at RemoteReality Corp., FMP Products, Inc., EpiEP, Inc., CMDBioscience, Inc., Innovatient Solutions, Inc., P2 Science, Inc., Synbody Biotechnology, Inc., and Azitra, Inc., Independent Director at IsoPlexis Corp.
from 2014 to 2023, Senior Managing Director at Connecticut Innovations, Inc. from 2018 to 2026, and Principal at CuraGen Corp.
Education includes undergraduate and MBA degrees from Quinnipiac University, and undergraduate studies at the University of Dayton.

Daniel Wagner active positions

CompaniesPositionStart
Corporate Officer/Principal -
Director/Board Member -
Director/Board Member -
Director/Board Member 30/11/2015
Director/Board Member -

Former positions of Daniel Wagner

CompaniesPositionEnd
Private Equity Investor 30/06/2026
ISOPLEXIS CORPORATION Director/Board Member 20/03/2023
AZITRA, INC. Director/Board Member -
Director/Board Member -
░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Daniel Wagner's experience

Training of Daniel Wagner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

75

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Finance

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Process Industries

Health Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology